Quit Genius logo

Quit Genius Funding & Investors

New York, NY

Quit Genius is the world’s first digital clinic for treating nicotine, alcohol and opioid addictions. Built on the evidence-based approach of Medication-Assisted Treatment (MAT), Quit Genius combines virtual cognitive behavioral therapy (CBT) with approved medication and connected devices to help employers and health plans tackle the high cost of addiction, while improving the lives of their employees and members.

quitgenius.com

Total Amount Raised: $136,600,000

Quit Genius Funding Rounds

  • Series C

    $58,000,000

    Series C Investors

    Atomico
    GreyMatter
    Eight Roads Ventures
    Y Combinator
    Octopus Ventures
    Kinnevik
  • Series B

    $64,000,000

    Series B Investors

    Atomico
    Kinnevik
    StartUp Health
    Octopus Ventures
    Triple Point
    Product Co-op
  • Series A

    $12,000,000

    Series A Investors

    Octopus Ventures
    Y Combinator
    StartUp Health
    Triple Point
    Venus Williams
    Serena Ventures
    Cur8 Capital
    Burda Principal Investments
  • Seed

    $2,600,000

    Seed Investors

    Telefónica
    Y Combinator
    Force Over Mass Capital
    Merck
    AAF Management
    Village Global
    Eric Ries
    Olivia Teich
    Juha Paananen
    Pioneer Fund
    Max Mullen
    Junaid Bajwa
    Paul Rosania
    David Langer
    Lionheart Ventures
    EQT Ventures
Funding info provided by Diffbot.